Designs and manufactures respiratory protection products. Offers advanced respiratory masks and filters. Now — the numbers.
This is an established company with proven profits.
Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.
The gap is $67.9M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 66.6× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades below its recent peak — about 15% off the top. A pullback, not a collapse.
It pays out $0.25 per share each year — regular cash for whoever holds the stock.
The company’s market value is 67 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.